HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Byron H Long Selected Research

BMS 250749

4/2005Discovery of a fluoroindolo[2,3-a]carbazole clinical candidate with broad spectrum antitumor activity in preclinical tumor models superior to the marketed oncology drug, CPT-11.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Byron H Long Research Topics

Disease

2Neoplasms (Cancer)
04/2005 - 03/2004
1Lewis Lung Carcinoma
04/2005
1Carcinoma (Carcinomatosis)
03/2004

Drug/Important Bio-Agent (IBA)

2carbazoleIBA
04/2005 - 03/2004
1Irinotecan (Camptosar)FDA LinkGeneric
04/2005
1Pharmaceutical PreparationsIBA
04/2005
1BMS 250749IBA
04/2005
13,9- difluoro- 12,13- dihydro- 13- (6- aminoglucopyranosyl)- 5H,13H- benzo(b)thienyl(2,3- a)pyrrolo(3,4- c)carbazole- 5,7(6H)- dioneIBA
03/2004